Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Goal-Directed Fluid Management in Hand-Assisted Laparoscopic Colectomy
NCT00467922Phase 3Completed
- Sponsor
- Corewell Health
- Start
- May 2007
- Primary completion
- Sep 2009
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hextend, lactated ringer's solution in Crohn's disease, ulcerative colitis (UC), rectal cancer, colon cancer, colon polyp, sponsored by Corewell Health. Started May 2007; status: completed.
02
Drugs
hextendlactated ringer's solution
03
Conditions
Crohn's diseaseulcerative colitis (UC)rectal cancercolon cancercolon polyp
Beyond the preview
Go deeper on NCT00467922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00467922.